Risk Minimisation Materials

Rixathon (rituximab) Healthcare Professional Educational Leaflet - Important safety information for healthcare professionals in treating patients with Rixathon therapy

This guide is intended to review key facts and important safety information about rituximab in non-oncology diseases and to provide important patient counselling information to assist healthcare professionals in caring for patients receiving rituximab therapy.

For Healthcare Professionals